NLM Logo

PECC protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
PECC protocol
Unique ID
C090906
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C090906
Entry Term(s)
adapted M-2 regimen
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Carmustine
Cyclophosphamide
Prednisone
Vindesine
Frequency
3
Note
chemotherapy protocol consisting of above compounds; used in the treatment of multiple myeloma
Source
J Clin Oncol 1994 Dec;12(12):2706-13
Date of Entry
1995/01/11
Revision Date
2000/11/30
PECC protocol Preferred
adapted M-2 regimen Narrower
page delivered in 0.004s